May 15, 2019
Powles T et al. Nature Medicine 2019;25:1706–1714.
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
You might also be interested by
Web News
CellCarta Launches Advanced AI-Powered Spatial Biology Data for Clinical Trials
March 1, 2022
Histopathology
More info